GTLLX
Price
$35.48
Change
-$0.07 (-0.20%)
Updated
Sep 20 closing price
RGEBX
Price
$73.82
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

GTLLX vs RGEBX

Header iconGTLLX vs RGEBX Comparison
Open Charts GTLLX vs RGEBXBanner chart's image
Glenmede Quant US Large Cap Gr Eq
Price$35.48
Change-$0.07 (-0.20%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.82
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GTLLX vs RGEBX Comparison Chart
Loading...
VS
GTLLX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTLLX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 290B vs. GTLLX (1.5B). RGEBX pays higher dividends than GTLLX: RGEBX (0.16) vs GTLLX (0.13). GTLLX was incepted earlier than RGEBX: GTLLX (21 years) vs RGEBX (10 years). GTLLX is a more actively managed with annual turnover of: 78.00 vs. RGEBX (31.00). GTLLX has a lower initial minimum investment than RGEBX: GTLLX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 22.86 vs. GTLLX (20.05). RGEBX return over 5 years is better than : 47.60 vs. GTLLX (9.19).
GTLLXRGEBXGTLLX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years10 years-
Gain YTD12.35918.89665%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.5B290B1%
Annual Yield % from dividends0.130.1685%
Returns for 1 year20.0522.8688%
Returns for 3 years-11.01-4.80230%
Returns for 5 years9.1947.6019%
Returns for 10 years58.9856.25105%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics